Gueudin 2016.
Study characteristics | |||
Patient Sampling | Clinical performance was evaluated relative to the Abbott RealTime HIV‐1 assay on 285 HIV‐1 seropositive samples selected to cover the assays quantification range (40 copies/mL to 10,000,000 copies/mL), and included RNA undetectable or detected seropositive samples. Samples collected during routine viral load measurements for 285 patients managed at the Charles Nicolle Hospital, Rouen, France. |
||
Patient characteristics and setting | Samples from 285 HIV‐1 seropositive patients (224 patients on ART and 59 untreated patients; no ART information available for 2 patients); lab setting in France. | ||
Index tests | Cepheid Xpert HIV‐1 Viral Load assay done on fresh plasma samples in a hospital laboratory in France. | ||
Target condition and reference standard(s) | High viral load > 40 copies/mL; Abbott RealTime HIV‐1 assay. | ||
Flow and timing | Fresh samples were stored at 2 °C to 8 °C and tested simultaneously by both techniques within 5 days of collection and separation, and frozen samples were tested simultaneously within the same freeze/thaw cycle. | ||
Comparative | |||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Unclear | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Could the selection of patients have introduced bias? | Unclear risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | Unclear risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Low risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Low risk |